VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_16-vv-00286
Package ID: USCOURTS-cofc-1_16-vv-00286
Petitioner: R.H.Q.
Filed: 2016-02-29
Decided: 2016-11-22
Vaccine: DTaP, hepatitis B, IPV, Hib, PCV, and rotavirus
Vaccination date: 2013-02-25
Condition: encephalopathy and passed away
Outcome: compensated
Award amount USD: 322915

AI-assisted case summary:
On February 29, 2016, Emily Claire Fontenot Quibodeaux, as the legal representative of the estate of her deceased son, R.H.Q., filed a petition under the National Vaccine Injury Compensation Program. The petition alleged that R.H.Q. suffered an encephalopathy and subsequently passed away on December 20, 2014, as a sequela of receiving diphtheria-tetanus-acellular pertussis (DTaP), hepatitis B (hep B), inactivated poliovirus (IPV), Haemophilus influenzae type b (Hib), pneumococcal conjugate (PCV), and rotavirus vaccines on February 25, 2013. The petition also stated that there had been no prior award or settlement of a civil action for damages on behalf of R.H.Q. as a result of his alleged injury and/or death. Respondent denied that the DTaP, hep B, IPV, Hib, PCV, or rotavirus vaccines caused R.H.Q.'s alleged encephalopathy and death, or any other injury. Despite maintaining these positions, the parties filed a joint stipulation on November 21, 2016, agreeing to settle the issues and award compensation. Chief Special Master Nora Beth Dorsey reviewed the stipulation, found it reasonable, and adopted it as the decision of the Court on November 22, 2016. The stipulated compensation included a lump sum of $275,000.00 payable to petitioner as the legal representative of R.H.Q.'s estate for all damages available under the Vaccine Act. Additionally, a lump sum of $47,915.93 was to be paid jointly to petitioner and Louisiana Healthcare Connections to reimburse a State of Louisiana Medicaid lien, with petitioner agreeing to endorse this payment to the State. The stipulation noted that attorneys' fees and costs would be addressed in later proceedings. Petitioner was represented by Milton Clay Ragsdale, IV of Ragsdale LLC, and respondent was represented by Voris Johnson. The public decision and stipulation do not provide R.H.Q.'s birth date, age at vaccination, symptom-onset timeline, hospitalization course, diagnostic testing, or specific findings from the death investigation. The stipulation stated that it should not be construed as an admission of causation by the United States or the Secretary of Health and Human Services.

Theory of causation field:
Petitioner Emily Claire Fontenot Quibodeaux, as legal representative of the estate of R.H.Q., filed a petition alleging that DTaP, hepatitis B, IPV, Hib, PCV, and rotavirus vaccines administered on February 25, 2013, caused R.H.Q. to suffer an encephalopathy, with death on December 20, 2014, alleged as a sequela of the vaccine-related injury. Respondent denied causation. The case was compensated via joint stipulation filed November 21, 2016, and adopted by Chief Special Master Nora Beth Dorsey on November 22, 2016. The public decision and stipulation do not provide details on the mechanism of injury, specific onset of symptoms, diagnostic testing, or death investigation findings. No litigated Althen findings or named experts are described in the public text. The award totaled $322,915.93, consisting of a $275,000.00 lump sum to the estate and $47,915.93 for reimbursement of a Louisiana Medicaid lien, payable jointly to petitioner and Louisiana Healthcare Connections. Attorneys for petitioner were Milton Clay Ragsdale, IV of Ragsdale LLC; respondent attorney was Voris Johnson.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_16-vv-00286-0
Date issued/filed: 2017-03-03
Pages: 8
Docket text: PUBLIC DECISION (Originally filed: 11/22/2016) regarding 28 DECISION Stipulation/Proffer ( Signed by Chief Special Master Nora Beth Dorsey.)(mpj) Copy to parties.
--------------------------------------------------------------------------------
Case 1:16-vv-00286-UNJ Document 38 Filed 03/03/17 Page 1 of 8
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 16-286V
Filed: November 22, 2016
UNPUBLISHED
* * * * * * * * * * * * * * * * * * * * * * * * * * * *
EMILY CLAIRE FONTENOT *
QUIBODEAUX, as legal representative *
Of the estate of her son, R.H.Q., *
*
Petitioner, *
v. * Joint Stipulation on Damages;
* Encephalopathy; Death;
SECRETARY OF HEALTH * Special Processing Unit (“SPU”)
AND HUMAN SERVICES, *
*
Respondent. *
*
* * * * * * * * * * * * * * * * * * * * * * * * * * * *
Milton Clay Ragsdale, IV, Ragsdale LLC, Birmingham, AL, for petitioner.
Voris Johnson, U.S. Department of Justice, Washington, DC, for respondent.
DECISION ON JOINT STIPULATION1
Dorsey, Chief Special Master:
On February 29, 2016, petitioner filed a petition for compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,2 (the
“Vaccine Act”). Petitioner alleges that R.H.Q. suffered an encephalopathy and passed
away as a result of receiving diphtheria-tetanus-acellular pertussis (“DTaP”), hepatitis B
(“hep B”), inactivated poliovirus (“IPV”), Haemophilus influenza type b (“Hib”),
pneumococcal conjugate (“PCV”), and rotavirus vaccines on February 25, 2013.
Petition at 1-3; Stipulation, filed November 21, 2016, at ¶¶ 1-4. Petitioner further alleges
that R.H.Q.’s death on December 20, 2014, was the sequela of his vaccine-related
injury and that there has been no prior award or settlement of a civil action for damages
on behalf of R.H.Q. as a result of his alleged injury and/or death. Petition at 4;
Stipulation at ¶¶ 4-5. “Respondent denies that the DTaP, hep B, IPV, Hib, PCV or
1 Because this unpublished decision contains a reasoned explanation for the action in this case, the
undersigned intends to post it on the United States Court of Federal Claims' website, in accordance with
the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of
Electronic Government Services). In accordance with Vaccine Rule 18(b), petitioner has 14 days to
identify and move to redact medical or other information, the disclosure of which would constitute an
unwarranted invasion of privacy. If, upon review, the undersigned agrees that the identified material fits
within this definition, the undersigned will redact such material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for
ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. §
300aa (2012).

Case 1:16-vv-00286-UNJ Document 38 Filed 03/03/17 Page 2 of 8
rotavirus vaccines caused R.H.Q.’s alleged encephalopathy and death, or any other
injury. ” Stipulation at ¶ 6.
Nevertheless, on November 21, 2016, the parties filed the attached joint
stipulation, stating that a decision should be entered awarding compensation. The
undersigned finds the stipulation reasonable and adopts it as the decision of the Court
in awarding damages, on the terms set forth therein.
The parties stipulate that petitioner shall receive the following compensation:
• A lump sum of $275,000.00 in the form of a check payable to
petitioner, as legal representative of the estate of R.H.Q., which
amount represents compensation for all damages that would be
available to petitioner under 42 U.S.C. § 300aa-15(a); and
• A lump sum of $47,915.93, which amount represents compensation
for reimbursement of a State of Louisiana Medicaid lien, in the form
of a check payable jointly to petitioner and Louisiana Healthcare
Connections, 5615 High Point Drive, Suite 100, Irving, Texas 75038,
with reference to Case No. 109989.
Stipulation at ¶ 8. Petitioner agrees to endorse this payment to the State. Id.
The undersigned approves the requested amount for petitioner’s compensation.
In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of
the court is directed to enter judgment in accordance with this decision.3
IT IS SO ORDERED.
s/Nora Beth Dorsey
Nora Beth Dorsey
Chief Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice
renouncing the right to seek review.
2

Case 1:16-vv-00286-UNJ Document 38 Filed 03/03/17 Page 3 of 8
IN THE UNITED STATES COURT OF FEDERAL CLAIMS
OFFICE OF SPECIAL MASTERS
__________________________________________
)
EMILY CLAIRE FONTENOT QUIBODEAUX, )
as legal representative of the estate )
of her son, R.H.Q., )
)
Petitioner, )
) No. 16-286V (ECF)
v. ) Chief Special Master Dorsey
)
SECRETARY OF HEALTH )
AND HUMAN SERVICES, )
)
Respondent. )
__________________________________________)
STIPULATION
The parties hereby stipulate to the following matters:
1. Emily Claire Fontenot Quibodeaux (“petitioner”), as legal representative of the
estate of her deceased son, R.H.Q., filed a petition for vaccine compensation under the National
Vaccine Injury Compensation Program, 42 U.S.C. §§ 300aa-10 to -34 (the “Vaccine Program”).
The petition seeks compensation for injuries to, and the death of, R.H.Q. allegedly caused by his
receipt of diphtheria-tetanus-acellular pertussis (“DTaP”), hepatitis B (“hep B”), inactivated
poliovirus (“IPV”), Haemophilus influenzae type b (“Hib”), pneumococcal conjugate (“PCV”)
and rotavirus vaccines, which vaccines are contained in the Vaccine Injury Table (the “Table”),
42 C.F.R. § 100.3(a).
2. R.H.Q. received the DTaP, hep B, IPV, Hib, PCV and rotavirus vaccines on
February 25, 2013.
3. The vaccines were administered within the United States.
4. Petitioner alleges that as a result of receiving the above-referenced vaccines,

Case 1:16-vv-00286-UNJ Document 38 Filed 03/03/17 Page 4 of 8
R.H.Q. suffered an encephalopathy. R.H.Q. passed away on December 20, 2014. Petitioner
further alleges that R.H.Q’s death was the sequela of his vaccine-related injury.
5. Petitioner represents that there has been no prior award or settlement of a civil
action for damages on behalf of R.H.Q. as a result of his alleged injury and/or death.
6. Respondent denies that the DTaP, hep B, IPV, Hib, PCV or rotavirus vaccines
caused R.H.Q’s alleged encephalopathy and death, or any other injury.
7. Maintaining their above-stated positions, the parties nevertheless now agree that
the issues between them shall be settled and that a decision should be entered awarding the
compensation described in paragraph 8 of this Stipulation.
8. As soon as practicable after an entry of judgment reflecting a decision consistent
with the terms of this Stipulation, and after petitioner has filed an election to receive
compensation pursuant to 42 U.S.C. § 300aa-21(a)(1), the Secretary of Health and Human
Services will issue the following vaccine compensation payment:
a. A lump sum of $275,000.00 in the form of a check payable to petitioner,
as legal representative of the estate of R.H.Q., which amount represents
compensation for all damages that would be available to petitioner under
42 U.S.C. § 300aa-15(a); and,
b. A lump sum of $47,915.93, which amount represents compensation for
reimbursement of a State of Louisiana Medicaid lien, in the form of a
check payable jointly to petitioner and Louisiana Healthcare Connections,
5615 High Point Drive, Suite 100, Irving, Texas 75038, with reference to
Case No. 109989. Petitioner agrees to endorse this payment to the State.
9. As soon as practicable after the entry of judgment on entitlement in this case, and
after petitioner has filed both a proper and timely election to receive compensation pursuant to
42 U.S.C. § 300aa-21(a)(1), and an application, the parties will submit to further proceedings
before the special master to award reasonable attorneys’ fees and costs incurred in proceeding
2

Case 1:16-vv-00286-UNJ Document 38 Filed 03/03/17 Page 5 of 8
upon this petition.
10. Petitioner and her attorney represent that compensation to be provided pursuant to
this Stipulation is not for any items or services for which the Program is not primarily liable
under 42 U.S.C. § 300aa-15(g), to the extent that payment has been made or can reasonably be
expected to be made under any State compensation programs, insurance policies, Federal or
State health benefits programs (other than Title XIX of the Social Security Act, 42 U.S.C. § 1396
et seq.), or by entities that provide health services on a pre-paid basis.
11. Payment made pursuant to paragraph 8 and any amounts awarded pursuant to
paragraph 9 of this Stipulation will be made in accordance with 42 U.S.C. § 300aa-15(i), subject
to the availability of sufficient statutory funds.
12. Petitioner represents that she presently is, or within 90 days of the date of
judgment will become, duly authorized to serve as legal representative of the estate of R.H.Q.
under the laws of the State of Louisiana. No payments pursuant to this Stipulation shall be made
until petitioner provides the Secretary with documentation establishing her appointment as legal
representative of the estate of R.H.Q. If petitioner is not authorized by a court of competent
jurisdiction to serve as legal representative of the estate of R.H.Q. at the time a payment pursuant
to this Stipulation is to be made, any such payment shall be paid to the party or parties appointed
by a court of competent jurisdiction to serve as legal representative of the estate of R.H.Q. upon
submission of written documentation of such appointment to the Secretary.
13. In return for the payments described in paragraphs 8 and 9, petitioner, in her
individual capacity, and as legal representative of the estate of R.H.Q, on behalf of herself,
R.H.Q. and his heirs, executors, administrators, successors or assigns, does forever irrevocably
and unconditionally release, acquit and discharge the Secretary of Health and Human Services
3

Case 1:16-vv-00286-UNJ Document 38 Filed 03/03/17 Page 6 of 8
and the United States of America from any and all actions or causes of action (including
agreements, judgments, claims, damages, loss of services, expenses and all demands of whatever
kind or nature) that have been brought, could have been brought, or could be timely brought in
the Court of Federal Claims, under the National Vaccine Injury Compensation Program, 42
U.S.C. § 300aa-10 et seq., on account of, or in any way growing out of, any and all known or
unknown, suspected or unsuspected personal injuries to, or death of, R.H.Q. resulting from, or
alleged to have resulted from, the DTaP, hep B, IPV, Hib, PCV and rotavirus vaccines
administered to R.H.Q. on February 25, 2013, as alleged by petitioner in a petition for vaccine
compensation filed on or about February 25, 2016, in the United States Court of Federal Claims
as petition No. 16-286V.
14. If the special master fails to issue a decision in complete conformity with the
terms of this Stipulation, or if the Court of Federal Claims fails to enter judgment in conformity
with a decision that is in complete conformity with the terms of this Stipulation, then the parties’
settlement and this Stipulation shall be voidable at the sole discretion of either party.
15. This Stipulation expresses a full and complete negotiated settlement of liability
and damages claimed under the National Vaccine Injury Act of 1986, as amended, except as
otherwise noted in paragraph 9 above. There is absolutely no agreement on the part of the
parties hereto to make any payment or to do any act or thing other than is herein expressly stated
and clearly agreed to. The parties further agree and understand that the award described in this
Stipulation may reflect a compromise of the parties’ respective positions as to liability and/or
amount of damages, and further, that a change in the nature of the injury or condition or in the
items of compensation sought, is not grounds to modify or revise this agreement.
16. This Stipulation shall not be construed as an admission by the United States of
4

Case 1:16-vv-00286-UNJ Document 38 Filed 03/03/17 Page 7 of 8
America or the Secretary of Health and Human Services that R.H.Q.’s alleged encephalopathy
and subsequent death, or any other injury, were caused-in-fact by the DTaP, hep B, IPV, Hib,
PCV and/or rotavirus vaccines.
17. All rights and obligations of petitioner hereunder shall apply equally to
petitioner’s heirs, successors and/or assigns.
END OF STIPULATION
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
5

Case 1:16-vv-00286-UNJ Document 38 Filed 03/03/17 Page 8 of 8